載入...
A new oral antiplatelet agent with potent antithrombotic properties: Comparison of DZ-697b with clopidogrel in a randomised phase I study
DZ-697b is a new orally active antiplatelet agent that inhibits collagen and ristocetin-mediated platelet activation. It does not require metabolisation to generate its active compound and has a safer profile than clopidogrel in pre-clinical studies. We compared the antithrombotic effects and bleedi...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3746984/ https://ncbi.nlm.nih.gov/pubmed/20062928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH09-06-0378 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|